Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1.
Ropars J +18 more
europepmc +1 more source
Evaluating Therapeutic Outcomes in Spinal Muscular Atrophy: An Indian Experience. [PDF]
Mohanlal S +8 more
europepmc +1 more source
Systematic Review and Meta-analysis of Long-Term Nusinersen Effectiveness in Adolescents and Adults with Spinal Muscular Atrophy. [PDF]
Hagenacker T +3 more
europepmc +1 more source
Biomarkers in spinal muscular atrophy. [PDF]
Yan L, Zhang J, Zheng J, Hao H.
europepmc +1 more source
Spontaan spinaal epiduraal hematoom bij acute rugpijn [PDF]
Anisau, Aliaksandr +2 more
core +1 more source
Quebec Spinal Muscular Atrophy Newborn Screening Program: The First Year Experience. [PDF]
Groulx-Boivin E +10 more
europepmc +1 more source
Managing Spinal Muscular Atrophy: A Look at the Biology and Treatment Strategies. [PDF]
Vezzoli A, Bottai D, Adami R.
europepmc +1 more source
Surgical Access for Intrathecal Therapy in Spinal Muscular Atrophy with Spinal Fusion: Long-Term Outcomes of Lumbar Laminectomy. [PDF]
Potaczek T, Duda S, Adamczyk J.
europepmc +1 more source
Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance. [PDF]
Belančić A +4 more
europepmc +1 more source
Single Nucleotide <i>SMN1</i> Variants in a Cohort of Individuals With Spinal Muscular Atrophy. [PDF]
Rimoldi M +11 more
europepmc +1 more source

